nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—Pigmentation skin—Methimazole—Graves' disease	0.107	0.159	CcSEcCtD
Trifluoperazine—Pigmentation skin—Propylthiouracil—Graves' disease	0.0907	0.135	CcSEcCtD
Trifluoperazine—Lupus-like syndrome—Methimazole—Graves' disease	0.0827	0.123	CcSEcCtD
Trifluoperazine—Lupus-like syndrome—Propylthiouracil—Graves' disease	0.0703	0.105	CcSEcCtD
Trifluoperazine—Pigmentation disorder—Methimazole—Graves' disease	0.0584	0.0871	CcSEcCtD
Trifluoperazine—Pigmentation disorder—Propylthiouracil—Graves' disease	0.0496	0.074	CcSEcCtD
Trifluoperazine—CYP1A2—Methimazole—Graves' disease	0.0267	1	CbGbCtD
Trifluoperazine—Liver injury—Propylthiouracil—Graves' disease	0.0197	0.0294	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Methimazole—Graves' disease	0.0183	0.0273	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Propylthiouracil—Graves' disease	0.0155	0.0232	CcSEcCtD
Trifluoperazine—S100A4—eye—Graves' disease	0.0149	0.063	CbGeAlD
Trifluoperazine—S100A4—connective tissue—Graves' disease	0.0144	0.0607	CbGeAlD
Trifluoperazine—EBPL—adipose tissue—Graves' disease	0.014	0.0589	CbGeAlD
Trifluoperazine—CALY—pituitary gland—Graves' disease	0.0128	0.0541	CbGeAlD
Trifluoperazine—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.0127	0.019	CcSEcCtD
Trifluoperazine—TNNC1—connective tissue—Graves' disease	0.0121	0.0511	CbGeAlD
Trifluoperazine—EBPL—thyroid gland—Graves' disease	0.0121	0.051	CbGeAlD
Trifluoperazine—S100A4—pituitary gland—Graves' disease	0.0111	0.0467	CbGeAlD
Trifluoperazine—S100A4—adipose tissue—Graves' disease	0.011	0.0465	CbGeAlD
Trifluoperazine—Drowsiness—Methimazole—Graves' disease	0.0109	0.0163	CcSEcCtD
Trifluoperazine—Jaundice—Methimazole—Graves' disease	0.0106	0.0158	CcSEcCtD
Trifluoperazine—Agranulocytosis—Methimazole—Graves' disease	0.0102	0.0152	CcSEcCtD
Trifluoperazine—S100A4—thyroid gland—Graves' disease	0.00954	0.0403	CbGeAlD
Trifluoperazine—TNNC1—pituitary gland—Graves' disease	0.00931	0.0393	CbGeAlD
Trifluoperazine—TNNC1—adipose tissue—Graves' disease	0.00927	0.0392	CbGeAlD
Trifluoperazine—Drowsiness—Propylthiouracil—Graves' disease	0.00926	0.0138	CcSEcCtD
Trifluoperazine—Jaundice—Propylthiouracil—Graves' disease	0.00903	0.0135	CcSEcCtD
Trifluoperazine—Agranulocytosis—Propylthiouracil—Graves' disease	0.00865	0.0129	CcSEcCtD
Trifluoperazine—TNNC1—thyroid gland—Graves' disease	0.00803	0.0339	CbGeAlD
Trifluoperazine—Leukopenia—Methimazole—Graves' disease	0.00762	0.0114	CcSEcCtD
Trifluoperazine—Leukopenia—Propylthiouracil—Graves' disease	0.00648	0.00967	CcSEcCtD
Trifluoperazine—Somnolence—Methimazole—Graves' disease	0.00618	0.00922	CcSEcCtD
Trifluoperazine—Urticaria—Methimazole—Graves' disease	0.00552	0.00824	CcSEcCtD
Trifluoperazine—Body temperature increased—Methimazole—Graves' disease	0.00549	0.0082	CcSEcCtD
Trifluoperazine—CALM3—eye—Graves' disease	0.00546	0.0231	CbGeAlD
Trifluoperazine—Somnolence—Propylthiouracil—Graves' disease	0.00525	0.00784	CcSEcCtD
Trifluoperazine—Pruritus—Methimazole—Graves' disease	0.00492	0.00734	CcSEcCtD
Trifluoperazine—SIGMAR1—eye—Graves' disease	0.00488	0.0206	CbGeAlD
Trifluoperazine—Urticaria—Propylthiouracil—Graves' disease	0.00469	0.007	CcSEcCtD
Trifluoperazine—Body temperature increased—Propylthiouracil—Graves' disease	0.00467	0.00697	CcSEcCtD
Trifluoperazine—Rash—Methimazole—Graves' disease	0.00438	0.00654	CcSEcCtD
Trifluoperazine—Dermatitis—Methimazole—Graves' disease	0.00438	0.00653	CcSEcCtD
Trifluoperazine—Headache—Methimazole—Graves' disease	0.00435	0.0065	CcSEcCtD
Trifluoperazine—CALM2—eye—Graves' disease	0.00429	0.0181	CbGeAlD
Trifluoperazine—CALM1—eye—Graves' disease	0.00427	0.018	CbGeAlD
Trifluoperazine—Pruritus—Propylthiouracil—Graves' disease	0.00418	0.00624	CcSEcCtD
Trifluoperazine—CALM2—connective tissue—Graves' disease	0.00413	0.0175	CbGeAlD
Trifluoperazine—Nausea—Methimazole—Graves' disease	0.00413	0.00616	CcSEcCtD
Trifluoperazine—CALM1—connective tissue—Graves' disease	0.00411	0.0174	CbGeAlD
Trifluoperazine—CALM3—pituitary gland—Graves' disease	0.00405	0.0171	CbGeAlD
Trifluoperazine—CALM3—adipose tissue—Graves' disease	0.00404	0.0171	CbGeAlD
Trifluoperazine—DRD2—eye—Graves' disease	0.00394	0.0167	CbGeAlD
Trifluoperazine—Rash—Propylthiouracil—Graves' disease	0.00373	0.00556	CcSEcCtD
Trifluoperazine—Dermatitis—Propylthiouracil—Graves' disease	0.00372	0.00555	CcSEcCtD
Trifluoperazine—Headache—Propylthiouracil—Graves' disease	0.0037	0.00552	CcSEcCtD
Trifluoperazine—SIGMAR1—pituitary gland—Graves' disease	0.00362	0.0153	CbGeAlD
Trifluoperazine—SIGMAR1—adipose tissue—Graves' disease	0.00361	0.0152	CbGeAlD
Trifluoperazine—Nausea—Propylthiouracil—Graves' disease	0.00351	0.00524	CcSEcCtD
Trifluoperazine—CALM3—thyroid gland—Graves' disease	0.0035	0.0148	CbGeAlD
Trifluoperazine—CALM2—pituitary gland—Graves' disease	0.00318	0.0135	CbGeAlD
Trifluoperazine—CALM2—adipose tissue—Graves' disease	0.00317	0.0134	CbGeAlD
Trifluoperazine—CALM1—pituitary gland—Graves' disease	0.00317	0.0134	CbGeAlD
Trifluoperazine—CALM1—adipose tissue—Graves' disease	0.00316	0.0133	CbGeAlD
Trifluoperazine—SIGMAR1—thyroid gland—Graves' disease	0.00312	0.0132	CbGeAlD
Trifluoperazine—HRH1—eye—Graves' disease	0.00311	0.0132	CbGeAlD
Trifluoperazine—HRH1—connective tissue—Graves' disease	0.003	0.0127	CbGeAlD
Trifluoperazine—ADRA1A—adipose tissue—Graves' disease	0.00297	0.0126	CbGeAlD
Trifluoperazine—DRD2—pituitary gland—Graves' disease	0.00293	0.0124	CbGeAlD
Trifluoperazine—CALM2—thyroid gland—Graves' disease	0.00274	0.0116	CbGeAlD
Trifluoperazine—CALM1—thyroid gland—Graves' disease	0.00273	0.0115	CbGeAlD
Trifluoperazine—HTR2A—eye—Graves' disease	0.0026	0.011	CbGeAlD
Trifluoperazine—HTR2A—connective tissue—Graves' disease	0.00251	0.0106	CbGeAlD
Trifluoperazine—HRH1—adipose tissue—Graves' disease	0.0023	0.00973	CbGeAlD
Trifluoperazine—CYP1A2—thyroid gland—Graves' disease	0.00213	0.00899	CbGeAlD
Trifluoperazine—HTR2A—pituitary gland—Graves' disease	0.00193	0.00816	CbGeAlD
Trifluoperazine—ABCB1—pituitary gland—Graves' disease	0.00127	0.00535	CbGeAlD
Trifluoperazine—ABCB1—adipose tissue—Graves' disease	0.00126	0.00532	CbGeAlD
Trifluoperazine—ABCB1—thyroid gland—Graves' disease	0.00109	0.00461	CbGeAlD
Trifluoperazine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000152	0.00228	CbGpPWpGaD
Trifluoperazine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000152	0.00228	CbGpPWpGaD
Trifluoperazine—CALM3—Alzheimers Disease—IL1B—Graves' disease	0.00015	0.00226	CbGpPWpGaD
Trifluoperazine—DRD2—Circadian rythm related genes—FAS—Graves' disease	0.000149	0.00224	CbGpPWpGaD
Trifluoperazine—CALM2—Alzheimers Disease—IL1B—Graves' disease	0.000145	0.00218	CbGpPWpGaD
Trifluoperazine—CALM1—Alzheimers Disease—IL1B—Graves' disease	0.000145	0.00218	CbGpPWpGaD
Trifluoperazine—CALM3—DAP12 interactions—HLA-B—Graves' disease	0.000143	0.00215	CbGpPWpGaD
Trifluoperazine—CALM2—Cardiac Hypertrophic Response—TNF—Graves' disease	0.000141	0.00212	CbGpPWpGaD
Trifluoperazine—CALM1—Cardiac Hypertrophic Response—TNF—Graves' disease	0.000141	0.00212	CbGpPWpGaD
Trifluoperazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.00014	0.0021	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—TSHR—Graves' disease	0.000139	0.00209	CbGpPWpGaD
Trifluoperazine—CALM2—DAP12 interactions—HLA-B—Graves' disease	0.000138	0.00208	CbGpPWpGaD
Trifluoperazine—CALM1—DAP12 interactions—HLA-B—Graves' disease	0.000138	0.00208	CbGpPWpGaD
Trifluoperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000136	0.00204	CbGpPWpGaD
Trifluoperazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000134	0.00201	CbGpPWpGaD
Trifluoperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000133	0.00201	CbGpPWpGaD
Trifluoperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000131	0.00197	CbGpPWpGaD
Trifluoperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000131	0.00197	CbGpPWpGaD
Trifluoperazine—ABCB1—Allograft Rejection—IFNG—Graves' disease	0.000127	0.00192	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—TSHR—Graves' disease	0.000126	0.0019	CbGpPWpGaD
Trifluoperazine—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	0.000126	0.00189	CbGpPWpGaD
Trifluoperazine—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	0.000122	0.00183	CbGpPWpGaD
Trifluoperazine—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	0.000122	0.00183	CbGpPWpGaD
Trifluoperazine—HTR1A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000121	0.00183	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR ligand binding—CXCL10—Graves' disease	0.000118	0.00177	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR ligand binding—CXCL10—Graves' disease	0.000117	0.00176	CbGpPWpGaD
Trifluoperazine—ABCB1—Allograft Rejection—IL1B—Graves' disease	0.000114	0.00171	CbGpPWpGaD
Trifluoperazine—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000113	0.00171	CbGpPWpGaD
Trifluoperazine—CALM3—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000112	0.00168	CbGpPWpGaD
Trifluoperazine—CALM3—Alzheimers Disease—TNF—Graves' disease	0.000109	0.00164	CbGpPWpGaD
Trifluoperazine—CALM2—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000108	0.00163	CbGpPWpGaD
Trifluoperazine—CALM1—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000108	0.00163	CbGpPWpGaD
Trifluoperazine—CALM2—Alzheimers Disease—TNF—Graves' disease	0.000105	0.00158	CbGpPWpGaD
Trifluoperazine—CALM1—Alzheimers Disease—TNF—Graves' disease	0.000105	0.00158	CbGpPWpGaD
Trifluoperazine—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000105	0.00158	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR ligand binding—CXCL10—Graves' disease	0.000103	0.00156	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	0.000103	0.00155	CbGpPWpGaD
Trifluoperazine—CHRM2—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000103	0.00155	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000102	0.00154	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—TSHR—Graves' disease	0.000102	0.00154	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	0.000102	0.00153	CbGpPWpGaD
Trifluoperazine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000102	0.00153	CbGpPWpGaD
Trifluoperazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000102	0.00153	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR ligand binding—CXCL10—Graves' disease	0.000101	0.00153	CbGpPWpGaD
Trifluoperazine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.0001	0.00151	CbGpPWpGaD
Trifluoperazine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.0001	0.00151	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR ligand binding—CXCL10—Graves' disease	9.99e-05	0.0015	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR ligand binding—CXCL10—Graves' disease	9.96e-05	0.0015	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	9.95e-05	0.0015	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—IFIH1—Graves' disease	9.89e-05	0.00149	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	9.59e-05	0.00144	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—IFIH1—Graves' disease	9.57e-05	0.00144	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—IFIH1—Graves' disease	9.57e-05	0.00144	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—TSHR—Graves' disease	9.35e-05	0.00141	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—TSHR—Graves' disease	9.3e-05	0.0014	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—TSHR—Graves' disease	9.04e-05	0.00136	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—CXCL10—Graves' disease	8.99e-05	0.00135	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	8.9e-05	0.00134	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—TSHR—Graves' disease	8.88e-05	0.00134	CbGpPWpGaD
Trifluoperazine—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	8.81e-05	0.00133	CbGpPWpGaD
Trifluoperazine—CALM3—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	8.75e-05	0.00132	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—TSHR—Graves' disease	8.73e-05	0.00131	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—TSHR—Graves' disease	8.71e-05	0.00131	CbGpPWpGaD
Trifluoperazine—CALM2—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	8.46e-05	0.00127	CbGpPWpGaD
Trifluoperazine—CALM1—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	8.46e-05	0.00127	CbGpPWpGaD
Trifluoperazine—ABCB1—Allograft Rejection—TNF—Graves' disease	8.25e-05	0.00124	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—TSHR—Graves' disease	8.21e-05	0.00124	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—CXCL10—Graves' disease	8.16e-05	0.00123	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—TSHR—Graves' disease	8.08e-05	0.00122	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—TSHR—Graves' disease	8.06e-05	0.00121	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—TSHR—Graves' disease	7.93e-05	0.00119	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—TSHR—Graves' disease	7.91e-05	0.00119	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—HLA-E—Graves' disease	7.78e-05	0.00117	CbGpPWpGaD
Trifluoperazine—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	7.61e-05	0.00114	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—GC—Graves' disease	7.54e-05	0.00113	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—HLA-E—Graves' disease	7.53e-05	0.00113	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—HLA-E—Graves' disease	7.53e-05	0.00113	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—HLA-E—Graves' disease	7.47e-05	0.00112	CbGpPWpGaD
Trifluoperazine—CHRM2—SIDS Susceptibility Pathways—TNF—Graves' disease	7.47e-05	0.00112	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TSHR—Graves' disease	7.46e-05	0.00112	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—CD40—Graves' disease	7.3e-05	0.0011	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—GC—Graves' disease	7.3e-05	0.0011	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—GC—Graves' disease	7.3e-05	0.0011	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—HLA-E—Graves' disease	7.23e-05	0.00109	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—HLA-E—Graves' disease	7.23e-05	0.00109	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—CTLA4—Graves' disease	7.2e-05	0.00108	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—CD40—Graves' disease	7.06e-05	0.00106	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—CD40—Graves' disease	7.06e-05	0.00106	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—CTLA4—Graves' disease	6.96e-05	0.00105	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—CTLA4—Graves' disease	6.96e-05	0.00105	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—IL2RA—Graves' disease	6.87e-05	0.00103	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—B3GNT2—Graves' disease	6.83e-05	0.00103	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—TSHR—Graves' disease	6.71e-05	0.00101	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	6.65e-05	0.001	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—CXCL10—Graves' disease	6.62e-05	0.000996	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—B3GNT2—Graves' disease	6.6e-05	0.000994	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—B3GNT2—Graves' disease	6.6e-05	0.000994	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—TSHR—Graves' disease	6.49e-05	0.000976	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—TSHR—Graves' disease	6.49e-05	0.000976	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—IL2RA—Graves' disease	6.24e-05	0.000939	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	6.04e-05	0.000909	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—CXCL10—Graves' disease	6.01e-05	0.000904	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—HLA-DQB1—Graves' disease	5.93e-05	0.000892	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	5.84e-05	0.000879	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—IL2RA—Graves' disease	5.77e-05	0.000868	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IFIH1—Graves' disease	5.76e-05	0.000867	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	5.75e-05	0.000865	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—CXCL10—Graves' disease	5.74e-05	0.000863	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—HLA-DQB1—Graves' disease	5.73e-05	0.000863	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—HLA-DQB1—Graves' disease	5.73e-05	0.000863	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GC—Graves' disease	5.72e-05	0.00086	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—B3GNT2—Graves' disease	5.72e-05	0.00086	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—CXCL10—Graves' disease	5.64e-05	0.000849	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—CXCL10—Graves' disease	5.63e-05	0.000847	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—IL2RA—Graves' disease	5.58e-05	0.00084	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—IL2RA—Graves' disease	5.58e-05	0.00084	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IFIH1—Graves' disease	5.57e-05	0.000838	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IFIH1—Graves' disease	5.57e-05	0.000838	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—HLA-B—Graves' disease	5.54e-05	0.000834	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—CD8A—Graves' disease	5.53e-05	0.000833	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—B3GNT2—Graves' disease	5.53e-05	0.000832	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—B3GNT2—Graves' disease	5.53e-05	0.000832	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TSHR—Graves' disease	5.52e-05	0.000831	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TSHR—Graves' disease	5.5e-05	0.000827	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—HLA-B—Graves' disease	5.36e-05	0.000807	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—HLA-B—Graves' disease	5.36e-05	0.000807	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—CD8A—Graves' disease	5.35e-05	0.000806	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—CD8A—Graves' disease	5.35e-05	0.000806	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—HLA-B—Graves' disease	5.32e-05	0.000801	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—CXCL10—Graves' disease	5.3e-05	0.000798	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	5.22e-05	0.000785	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—CXCL10—Graves' disease	5.21e-05	0.000784	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—HLA-B—Graves' disease	5.15e-05	0.000775	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—HLA-B—Graves' disease	5.15e-05	0.000775	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—CXCL10—Graves' disease	5.13e-05	0.000771	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—CXCL10—Graves' disease	5.11e-05	0.000769	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	5.09e-05	0.000765	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—IL2RA—Graves' disease	5.06e-05	0.000761	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—HLA-A—Graves' disease	4.93e-05	0.000742	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TSHR—Graves' disease	4.85e-05	0.00073	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CXCL10—Graves' disease	4.82e-05	0.000725	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—HLA-A—Graves' disease	4.77e-05	0.000718	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—HLA-A—Graves' disease	4.77e-05	0.000718	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TSHR—Graves' disease	4.77e-05	0.000718	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TSHR—Graves' disease	4.76e-05	0.000716	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TSHR—Graves' disease	4.69e-05	0.000705	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TSHR—Graves' disease	4.67e-05	0.000703	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	4.62e-05	0.000695	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—IL2RA—Graves' disease	4.59e-05	0.000691	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GC—Graves' disease	4.56e-05	0.000687	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HLA-E—Graves' disease	4.53e-05	0.000682	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—HLA-DRB1—Graves' disease	4.51e-05	0.000678	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	4.46e-05	0.000672	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD40—Graves' disease	4.43e-05	0.000666	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	4.39e-05	0.000661	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HLA-E—Graves' disease	4.38e-05	0.00066	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HLA-E—Graves' disease	4.38e-05	0.00066	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—IL2RA—Graves' disease	4.38e-05	0.00066	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CTLA4—Graves' disease	4.37e-05	0.000657	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—HLA-DRB1—Graves' disease	4.36e-05	0.000656	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—HLA-DRB1—Graves' disease	4.36e-05	0.000656	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—CXCL10—Graves' disease	4.33e-05	0.000652	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—B3GNT2—Graves' disease	4.33e-05	0.000652	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—ICAM1—Graves' disease	4.33e-05	0.000651	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—IL2RA—Graves' disease	4.31e-05	0.000649	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—IL2RA—Graves' disease	4.3e-05	0.000647	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD40—Graves' disease	4.28e-05	0.000645	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD40—Graves' disease	4.28e-05	0.000645	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CTLA4—Graves' disease	4.22e-05	0.000635	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CTLA4—Graves' disease	4.22e-05	0.000635	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—CXCL10—Graves' disease	4.19e-05	0.000631	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—CXCL10—Graves' disease	4.19e-05	0.000631	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—ICAM1—Graves' disease	4.18e-05	0.00063	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—ICAM1—Graves' disease	4.18e-05	0.00063	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	4.07e-05	0.000613	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL2RA—Graves' disease	4.05e-05	0.00061	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	3.99e-05	0.0006	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL2RA—Graves' disease	3.98e-05	0.000599	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TSHR—Graves' disease	3.96e-05	0.000596	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL2RA—Graves' disease	3.92e-05	0.000589	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL2RA—Graves' disease	3.91e-05	0.000588	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TSHR—Graves' disease	3.83e-05	0.000577	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TSHR—Graves' disease	3.83e-05	0.000577	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL2RA—Graves' disease	3.69e-05	0.000554	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HLA-DQB1—Graves' disease	3.59e-05	0.000541	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CXCL10—Graves' disease	3.57e-05	0.000537	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CXCL10—Graves' disease	3.55e-05	0.000534	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HLA-DQB1—Graves' disease	3.48e-05	0.000523	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HLA-DQB1—Graves' disease	3.48e-05	0.000523	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—B3GNT2—Graves' disease	3.46e-05	0.00052	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD8A—Graves' disease	3.36e-05	0.000505	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL2RA—Graves' disease	3.31e-05	0.000498	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—CD4—Graves' disease	3.31e-05	0.000498	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD8A—Graves' disease	3.25e-05	0.000489	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD8A—Graves' disease	3.25e-05	0.000489	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HLA-B—Graves' disease	3.23e-05	0.000486	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL2RA—Graves' disease	3.2e-05	0.000482	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL2RA—Graves' disease	3.2e-05	0.000482	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—CD4—Graves' disease	3.2e-05	0.000482	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—CD4—Graves' disease	3.2e-05	0.000482	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—CD4—Graves' disease	3.18e-05	0.000478	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CXCL10—Graves' disease	3.13e-05	0.000471	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HLA-B—Graves' disease	3.12e-05	0.00047	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HLA-B—Graves' disease	3.12e-05	0.00047	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CXCL10—Graves' disease	3.08e-05	0.000464	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CXCL10—Graves' disease	3.08e-05	0.000463	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—CD4—Graves' disease	3.07e-05	0.000463	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—CD4—Graves' disease	3.07e-05	0.000463	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CXCL10—Graves' disease	3.03e-05	0.000456	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL2RA—Graves' disease	3.03e-05	0.000455	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CXCL10—Graves' disease	3.02e-05	0.000454	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HLA-A—Graves' disease	2.99e-05	0.00045	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL2RA—Graves' disease	2.93e-05	0.00044	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL2RA—Graves' disease	2.93e-05	0.00044	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HLA-A—Graves' disease	2.89e-05	0.000435	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HLA-A—Graves' disease	2.89e-05	0.000435	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—HLA-A—Graves' disease	2.76e-05	0.000416	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HLA-DRB1—Graves' disease	2.73e-05	0.000411	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL2RA—Graves' disease	2.73e-05	0.00041	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL2RA—Graves' disease	2.71e-05	0.000408	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—HLA-A—Graves' disease	2.67e-05	0.000402	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—HLA-A—Graves' disease	2.67e-05	0.000402	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HLA-DRB1—Graves' disease	2.64e-05	0.000398	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HLA-DRB1—Graves' disease	2.64e-05	0.000398	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—ICAM1—Graves' disease	2.62e-05	0.000395	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CXCL10—Graves' disease	2.56e-05	0.000385	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—ICAM1—Graves' disease	2.54e-05	0.000382	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—ICAM1—Graves' disease	2.54e-05	0.000382	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CXCL10—Graves' disease	2.48e-05	0.000373	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CXCL10—Graves' disease	2.48e-05	0.000373	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL2RA—Graves' disease	2.4e-05	0.00036	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL2RA—Graves' disease	2.36e-05	0.000355	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL2RA—Graves' disease	2.35e-05	0.000354	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL2RA—Graves' disease	2.31e-05	0.000348	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL2RA—Graves' disease	2.31e-05	0.000347	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IFNG—Graves' disease	2e-05	0.0003	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL2RA—Graves' disease	1.96e-05	0.000294	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IFNG—Graves' disease	1.93e-05	0.000291	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IFNG—Graves' disease	1.93e-05	0.000291	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD4—Graves' disease	1.93e-05	0.00029	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL2RA—Graves' disease	1.89e-05	0.000285	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL2RA—Graves' disease	1.89e-05	0.000285	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD4—Graves' disease	1.87e-05	0.000281	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD4—Graves' disease	1.87e-05	0.000281	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL1B—Graves' disease	1.78e-05	0.000268	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CD4—Graves' disease	1.78e-05	0.000268	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL1B—Graves' disease	1.72e-05	0.000259	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL1B—Graves' disease	1.72e-05	0.000259	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CD4—Graves' disease	1.72e-05	0.000259	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CD4—Graves' disease	1.72e-05	0.000259	CbGpPWpGaD
